Geoffrey D. Wool PhD, MD

Clinical Expertise
AnticoagulantsAntiphospholipid SyndromeBlood Coagulation DisordersDisseminated Intravascular CoagulationHematologic NeoplasmsLeukemiaLymphomaMyeloproliferative DisordersPathologyPathology, ClinicalPlatelet AggregationPlatelet Function TestsThrombosisvon Willebrand DiseasesPublications (64)
Advances in Hemostasis Laboratory Testing. (Wool GD) Clin Lab Med 2026 Jun;46(2):xiii-xiv PMID: 42140692 SCOPUS ID: 2-s2.0-105035234129 05/16/2026 Updates in Antiphospholipid Syndrome Laboratory Diagnosis. (Wool GD) Clin Lab Med 2026 Jun;46(2):295-311 PMID: 42140686 SCOPUS ID: 2-s2.0-105034697059 05/16/2026 Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia. (Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A) J Thromb Haemost 2026 Jul;24(7):2514-2521 PMID: 41936925 PMCID: PMC13189683 SCOPUS ID: 2-s2.0-105037812861 04/06/2026 1 CitationTargeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients. (Cannova JM, DuVall AS, Kline J, Feinberg N, Wool GD, Riedell PA) J Natl Compr Canc Netw 2026 Feb 19;24(3):128-131 PMID: 41771248 PMCID: PMC13077976 SCOPUS ID: 2-s2.0-105033244434 03/03/2026 1 CitationD-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program. (Salazar E, Smock KJ, Cazzolli T, Dlott JS, Lickteig N, Long TA, Mulvey JJ, Gil MR, Rollins-Raval M, Teruya J, Volod O, Walker CA, Wool GD, Zantek ND, Goodwin Iv AJ) Semin Thromb Hemost 2026 Mar 06 PMID: 41651008 SCOPUS ID: 2-s2.0-105032106490 02/07/2026 Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia. (Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A) medRxiv 2025 Nov 27 PMID: 41358289 PMCID: PMC12676393 12/08/2025 Pharmacogenomic Testing: Strategies and Technical Considerations for Clinical Laboratories. (Ji Y, Brunk L, Bove B, Danyal K, Langman LJ, Mot N, Mroz P, Natowicz M, Reddi H, Shirts B, Smock K, Wool GD, Zhang BM, Moyer AM) Arch Pathol Lab Med 2025 Nov 22;150(5):339-353 PMID: 41270809 SCOPUS ID: 2-s2.0-105037109101 11/22/2025 The Role of Therapeutic Plasma Exchange in Treating Hypertriglyceridemia-Associated Acute Pancreatitis: A Real-World Effectiveness Analysis Using the TriNetX Global Collaborative Network. (Amin N, Carll T, Chela H, Kamran A, Wool GD, Daglilar E) J Clin Apher 2025 Aug;40(4):e70053 PMID: 40873124 SCOPUS ID: 2-s2.0-105014502460 08/28/2025 2 CitationsKaryotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. (Pandiri M, Stengel A, Zhang J, Wang P, Shao H, Velmurugan S, Jacob A, Symes E, Kaur A, Rojek A, Sojitra P, Wiredja D, Zhou Q, Chang H, Patil E, Patel JL, Patel AB, Menon M, Ghosh S, Wool GD, Arber DA, Pan Z, Findley A, Badar T, Tariq H, Sallman D, Bell RC, Perry A, Haferlach C, Fitzpatrick C, Venkataraman G) J Clin Pathol 2025 Aug 18;78(9):629-635 PMID: 40571403 SCOPUS ID: 2-s2.0-105009870305 06/27/2025 3 CitationsAssessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis. (Zhao K, Saucedo E, Basterrechea KF, Yang S, Haworth KJ, Holland CK, Racadio JM, Maxwell AD, Cursio JF, Wool GD, Ostdiek AM, Ahmed OS, Paul JD, Patel MV, Bader KB) J Vasc Interv Radiol 2025 Jun;36(6):1051-1061.e5 PMID: 39890017 PMCID: PMC12103285 SCOPUS ID: 2-s2.0-105000075996 02/01/2025 1 CitationRatios of calcium to citrate administration in blood transfusion for traumatic hemorrhage: A retrospective cohort study. (Alghanem H, Liu NC, Gupta A, Liao C, Wool GD, Rubin DS, Carll T) Transfusion 2024 Nov;64(11):2104-2113 PMID: 39351914 PMCID: PMC11573635 SCOPUS ID: 2-s2.0-85205519888 10/01/2024 5 CitationsCancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. (Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B) J Natl Compr Canc Netw 2024 Sep;22(7):483-506 PMID: 39236759 SCOPUS ID: 2-s2.0-85203420343 09/06/2024 69 CitationsManagement Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential. (McCartin MP, Wool GD, Thomas SA, Panfil M, Schoenfeld D, Blumen IJ, Tataris KL, Thomas SH) Air Med J 2024;43(4):348-356 PMID: 38897700 SCOPUS ID: 2-s2.0-85192143019 06/20/2024 1 CitationThe utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testing. (Mehr NA, Storozuk TE, Mikrut KL, Wool GD) Am J Clin Pathol 2024 Oct 03;162(4):379-391 PMID: 38741421 SCOPUS ID: 2-s2.0-85205741145 05/14/2024 1 CitationDilute Russell viper venom time interpretation: Influence of lot changes and normalization. (Wool GD) Am J Clin Pathol 2024 Oct 03;162(4):426-428 PMID: 38703058 SCOPUS ID: 2-s2.0-85205741001 05/05/2024 1 CitationPredictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. (Crane GM, Geyer JT, Thakral B, Wang SA, Wool GD, Li KD, Davis AR, Boiocchi L, Bosler D, Bueso-Ramos CE, Arber DA, George TI, Bagg A, Hasserjian RP, Orazi A, Hsi ED, Rogers HJ) Am J Clin Pathol 2024 Sep 03;162(3):233-242 PMID: 38597584 SCOPUS ID: 2-s2.0-85197676403 04/10/2024 6 CitationsEditorial: The immunological role of platelet activation in the pathophysiology of COVID-19. (Rossouw TM, Pretorius E, Wool GD) Front Immunol 2023;14:1285355 PMID: 37818358 PMCID: PMC10562013 SCOPUS ID: 2-s2.0-85173615870 10/11/2023 Viscoelastic testing: Critical appraisal of new methodologies and current literature. (Wool GD, Carll T) Int J Lab Hematol 2023 Oct;45(5):643-658 PMID: 37559473 SCOPUS ID: 2-s2.0-85167401338 08/10/2023 20 CitationsSensitivity and specificity of thromboelastography for hyperfibrinolysis: Comparison of TEG 5000 and TEG 6S CK LY30 systems. (Fuja C, Carll TC, Mikrut K, Wool GD) Am J Clin Pathol 2023 Nov 02;160(5):455-465 PMID: 37415401 SCOPUS ID: 2-s2.0-85176495226 07/07/2023 5 CitationsTreatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic? (Sarkar A, Khandelwal S, Koma GT, Kim H, Gruel Y, Rollin J, Passam F, Wool GD, Arepally GM, Cines DB, Rauova L, Poncz M) Blood Adv 2023 Aug 08;7(15):4112-4123 PMID: 37196641 PMCID: PMC10388731 SCOPUS ID: 2-s2.0-85169330094 05/18/2023 10 CitationsClinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. (Roloff GW, Wen F, Ramsland A, Artz AS, Kosuri S, Stock W, Odenike O, Larson RA, Liu H, Godley LA, Thirman MJ, Patel AA, Daugherty CK, DuVall AS, Nawas MT, Dworkin E, Wool GD, Gurbuxani S, Fitzpatrick C, Segal JP, Wang P, Drazer MW) Haematologica 2023 Aug 01;108(8):2234-2239 PMID: 36655425 PMCID: PMC10388285 SCOPUS ID: 2-s2.0-85166392357 01/20/2023 3 CitationsDecreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology. (Johnson B, Bucio J, Salerno C, Jeevanandam V, Song T, Wool G) J Card Surg 2022 Dec;37(12):5011-5018 PMID: 36349705 PMCID: PMC10099649 SCOPUS ID: 2-s2.0-85141557426 11/10/2022 1 CitationAnalysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program. (Salazar E, Long TA, Smock KJ, Wool GD, Rollins-Raval M, Chen D, Harris NS, Chan CW, Olson JD, Pham HP, Ritter J, Unold D, VanSandt AM, Goodwin Iv AJ) Semin Thromb Hemost 2022 Sep;48(6):690-699 PMID: 36223772 10/13/2022 Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program. (Salazar E, Long TA, Smock KJ, Wool GD, Rollins-Raval M, Chen D, Harris NS, Chan CW, Olson JD, Pham HP, Ritter J, Unold D, VanSandt AM, Goodwin Iv AJ) Semin Thromb Hemost 2022 Sep;48(6):690-699 PMID: 36055272 SCOPUS ID: 2-s2.0-85187624490 09/03/2022 Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. (Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A) Blood 2022 Dec 22;140(25):2722-2729 PMID: 35998675 PMCID: PMC9837435 SCOPUS ID: 2-s2.0-85139181944 08/24/2022 10 CitationsHyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. (Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD) Transfusion 2022 Jul;62(7):1446-1451 PMID: 35588309 PMCID: PMC9347625 SCOPUS ID: 2-s2.0-85130879184 05/20/2022 14 CitationsAlloimmunization rates in transfused patients receiving anti-CD47 antibody therapy. (Carll T, Mei Z, Aldarweesh F, Wool GD) Transfusion 2022 Apr;62(4):916-918 PMID: 35383955 SCOPUS ID: 2-s2.0-85127516494 04/07/2022 1 CitationPersistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. (Kanack AJ, Singh B, George G, Gundabolu K, Koepsell SA, Abou-Ismail MY, Moser KA, Smock KJ, Green D, Major A, Chan CW, Wool GD, Reding M, Ashrani AA, Bayas A, Grill DE, Padmanabhan A) Am J Hematol 2022 May;97(5):519-526 PMID: 35132672 PMCID: PMC8986571 SCOPUS ID: 2-s2.0-85124884409 02/09/2022 40 Citations(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy. (Hendley SA, Bhargava A, Holland CK, Wool GD, Ahmed O, Paul JD, Bader KB) PLoS One 2022;17(1):e0261567 PMID: 34982784 PMCID: PMC8726487 SCOPUS ID: 2-s2.0-85122284950 01/05/2022 14 CitationsAssessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi. (Hendley SA, Dimov A, Bhargava A, Snoddy E, Mansour D, Afifi RO, Wool GD, Zha Y, Sammet S, Lu ZF, Ahmed O, Paul JD, Bader KB) Sci Rep 2021 Nov 23;11(1):22805 PMID: 34815441 PMCID: PMC8610976 SCOPUS ID: 2-s2.0-85119856282 11/25/2021 22 CitationsRefractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). (Major A, Carll T, Chan CW, Christenson C, Aldarweesh F, Wool GD, Cohen KS) J Clin Apher 2022 Feb;37(1):117-121 PMID: 34672380 SCOPUS ID: 2-s2.0-85117411377 10/22/2021 17 CitationsThe Effect of RBC Transfusion on Oxygenation Status. (Carll T, Aldarweesh F, Christenson C, Wool GD) Am J Clin Pathol 2022 Mar 03;157(3):477 PMID: 34596218 SCOPUS ID: 2-s2.0-85125682284 10/02/2021 2 CitationsInterlaboratory Performance in Measurement of Dabigatran and Rivaroxaban. (Volod O, Rollins-Raval M, Goodwin AJ, Higgins RA, Long T, Chandler WL, Harris NS, Pham HP, Isom JA, Moser K, Olson JD, Smock KJ, VanSandt A, Wool G, Chen D) Arch Pathol Lab Med 2022 Jan 02;146(2):145-153 PMID: 34133726 SCOPUS ID: 2-s2.0-85123876508 06/17/2021 6 CitationsComparison of Viscoelastic Testing by Rotational Torsion and Harmonic Resonance Methods. (Pham HP, Azad A, Gounlong J, Gutierrez J, Mikrut K, Miller JL, Wool GD) Am J Clin Pathol 2021 Oct 13;156(5):818-828 PMID: 33978149 SCOPUS ID: 2-s2.0-85118598392 05/13/2021 8 CitationsPlatelet-rich aggregates in MNC collection circuit. (Amin N, Cho JH, McMullen P, Uraizee I, Wool G, Su L) Transfusion 2021 Apr;61(4):1010-1011 PMID: 33660852 SCOPUS ID: 2-s2.0-85101900320 03/05/2021 1 CitationFunctional Assessment of Platelet Dense Granule ATP Release. (Cho JH, Wool GD, Tjota MY, Gutierrez J, Mikrut K, Miller JL) Am J Clin Pathol 2021 May 18;155(6):863-872 PMID: 33386737 SCOPUS ID: 2-s2.0-85106667625 01/03/2021 8 CitationsBasic principles of viscoelastic testing. (Carll T, Wool GD) Transfusion 2020 Oct;60 Suppl 6:S1-S9 PMID: 33089939 SCOPUS ID: 2-s2.0-85093531718 10/23/2020 71 CitationsThe Impact of COVID-19 Disease on Platelets and Coagulation. (Wool GD, Miller JL) Pathobiology 2021;88(1):15-27 PMID: 33049751 PMCID: PMC7649697 SCOPUS ID: 2-s2.0-85094191652 10/14/2020 394 CitationsClinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. (Madariaga MLL, Guthmiller JJ, Schrantz S, Jansen MO, Christensen C, Kumar M, Prochaska M, Wool G, Durkin-Celauro A, Oh WH, Trockman L, Vigneswaran J, Keskey R, Shaw DG, Dugan H, Zheng NY, Cobb M, Utset H, Wang J, Stovicek O, Bethel C, Matushek S, Giurcanu M, Beavis KG, di Sabato D, Meltzer D, Ferguson MK, Kress JP, Shanmugarajah K, Matthews JB, Fung JF, Wilson PC, Alverdy JC, Donington JS) J Intern Med 2021 Apr;289(4):559-573 PMID: 33034095 PMCID: PMC7675325 SCOPUS ID: 2-s2.0-85096709442 10/10/2020 34 CitationsConfirming Point-of-Care INR Test Results-Reply. (Anderson I, Wool GD, Madden W) JAMA 2020 Mar 24;323(12):1191-1192 PMID: 32207790 SCOPUS ID: 2-s2.0-85082288091 03/25/2020 1 CitationThe Point-of-Care INR Test for Vitamin K Antagonist Monitoring. (Anderson I, Wool GD, Madden W) JAMA 2019 Dec 03;322(21):2129-2130 PMID: 31603458 SCOPUS ID: 2-s2.0-85073675374 10/12/2019 5 CitationsImpact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing. (Mei Z, Wool GD) Hematol Oncol Clin North Am 2019 Oct;33(5):797-811 PMID: 31466605 SCOPUS ID: 2-s2.0-85069872053 08/31/2019 12 CitationsHow I investigate bone marrow necrosis. (Deucher A, Wool GD) Int J Lab Hematol 2019 Oct;41(5):585-592 PMID: 31424633 SCOPUS ID: 2-s2.0-85070803212 08/20/2019 13 CitationsEffective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation. (Misra MK, Xin JJ, Brown NK, Weidner JG, Upchurch RL, Bishop MR, Wool GD, Artz AS, Marino SR) HLA 2019 Sep;94(3):307-311 PMID: 31314169 SCOPUS ID: 2-s2.0-85070725763 07/18/2019 6 CitationsPlasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. (Cho JH, Parilla M, Treml A, Wool GD) J Clin Apher 2019 Feb;34(1):64-72 PMID: 30407650 SCOPUS ID: 2-s2.0-85056203793 11/09/2018 12 CitationsBenefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review. (Wool GD) Am J Clin Pathol 2019 Jan 01;151(1):1-17 PMID: 30215666 SCOPUS ID: 2-s2.0-85058532289 09/15/2018 29 CitationsRed blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB. (Biller E, Zhao Y, Berg M, Boggio L, Capocelli KE, Fang DC, Koepsell S, Music-Aplenc L, Pham HP, Treml A, Weiss J, Wool G, Baron BW) Transfusion 2018 Aug;58(8):1965-1972 PMID: 30198607 SCOPUS ID: 2-s2.0-85053051001 09/11/2018 44 CitationsDilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review. (Jacquot C, Wool GD, Kogan SC) Int J Lab Hematol 2019 Feb;41(1):80-86 PMID: 30194751 SCOPUS ID: 2-s2.0-85052963556 09/09/2018 3 CitationsThe management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review. (Shunkwiler SM, Pham HP, Wool G, Ipe TS, Fang DC, Biller E, Treml A, Weiss J, Baron BW, Berg M, Therapeutic Apheresis Subsection of the AABB) J Clin Apher 2018 Jun;33(3):371-379 PMID: 29071747 SCOPUS ID: 2-s2.0-85032284961 10/27/2017 30 CitationsClinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva. (Wentworth KL, Bigay K, Chan TV, Ho JP, Morales BM, Connor J, Brooks E, Shahriar Salamat M, Sanchez HC, Wool G, Pignolo RJ, Kaplan FS, Hsiao EC) Bone 2018 Apr;109:104-110 PMID: 29033382 SCOPUS ID: 2-s2.0-85045167898 10/17/2017 20 CitationsAcquired factor XI deficiency and therapeutic plasma exchange. (Wool GD, Treml A, Miller JL) J Clin Apher 2018 Jun;33(3):427-430 PMID: 29027258 SCOPUS ID: 2-s2.0-85031395370 10/14/2017 6 CitationsTherapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism. (Wool GD, Chapel D, Treml A, Miller JL) Transfusion 2017 Jul;57(7):1827-1832 PMID: 28436106 SCOPUS ID: 2-s2.0-85018921107 04/25/2017 5 CitationsThe Hidden Lesion. (Wool G) N Engl J Med 2016 Sep 22;375(12):1198-9 PMID: 27653585 09/23/2016 A superior method for cell block preparation for fine-needle aspiration biopsies. (Balassanian R, Wool GD, Ono JC, Olejnik-Nave J, Mah MM, Sweeney BJ, Liberman H, Ljung BM, Pitman MB) Cancer Cytopathol 2016 Jul;124(7):508-18 PMID: 27105161 SCOPUS ID: 2-s2.0-84978786125 04/23/2016 73 CitationsBone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. (Wool GD, Deucher A) Am J Clin Pathol 2015 Feb;143(2):201-13; quiz 306 PMID: 25596246 SCOPUS ID: 2-s2.0-84925286295 01/18/2015 34 CitationsMimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut? (Wool GD, Reardon CA, Getz GS) J Lipid Res 2014 Oct;55(10):1983-5 PMID: 25085258 PMCID: PMC4173990 SCOPUS ID: 2-s2.0-84907532877 08/03/2014 9 CitationsPathology consultation on anticoagulation monitoring: factor X-related assays. (Wool GD, Lu CM, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists) Am J Clin Pathol 2013 Nov;140(5):623-34 PMID: 24124140 SCOPUS ID: 2-s2.0-84886295541 10/15/2013 26 Citations4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. (Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS) FASEB J 2011 Jan;25(1):290-300 PMID: 20876212 PMCID: PMC3005429 SCOPUS ID: 2-s2.0-79251573524 09/30/2010 45 CitationsHDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. (Getz GS, Wool GD, Reardon CA) Curr Pharm Des 2010;16(28):3173-84 PMID: 20687877 PMCID: PMC3087816 SCOPUS ID: 2-s2.0-78649861855 08/07/2010 37 CitationsBiological properties of apolipoprotein a-I mimetic peptides. (Getz GS, Wool GD, Reardon CA) Curr Atheroscler Rep 2010 Mar;12(2):96-104 PMID: 20425244 PMCID: PMC3087815 SCOPUS ID: 2-s2.0-77953536667 04/29/2010 32 CitationsAn apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. (Wool GD, Vaisar T, Reardon CA, Getz GS) J Lipid Res 2009 Sep;50(9):1889-900 PMID: 19433476 PMCID: PMC2724789 SCOPUS ID: 2-s2.0-68749118094 05/13/2009 40 CitationsApoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. (Getz GS, Wool GD, Reardon CA) Curr Opin Lipidol 2009 Jun;20(3):171-5 PMID: 19373084 SCOPUS ID: 2-s2.0-67049158641 04/18/2009 35 CitationsApolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. (Wool GD, Reardon CA, Getz GS) J Lipid Res 2008 Jun;49(6):1268-83 PMID: 18323574 PMCID: PMC3837452 SCOPUS ID: 2-s2.0-48549096875 03/08/2008 69 CitationsThe influence of acute phase proteins on murine atherosclerosis. (Wool GD, Reardon CA) Curr Drug Targets 2007 Nov;8(11):1203-14 PMID: 18045099 SCOPUS ID: 2-s2.0-36949031690 11/30/2007 6 Citations Last update: 06/21/2026